Terms and Conditions
Advertisement
Advertisement
Trending on Modern Retina
1
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice
2
StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101
3
Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence
4
Geographic atrophy: When lesion borders cannot be graded
5